Toggle navigation
Home
Search
Services
Blog
Contact
About
Nucleotide Dimers as Anti-HIV Agents
Hahn, Elliot F.
Baker Norton Pharmaceuticals, Inc., Miami, FL, United States
Search 7 grants from Elliot Hahn
Search grants from Baker Norton Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
South Dakota Rape Prevention Education Grant
Clinical Practice Data to Aid Narrow Therapeutic Index Drug Classification
Cognitive control and the functional organization of frontal cortex
The Role of Trp Proteins in Myometrial Calcium Dynamics
RNA Tertiary Structure
Recently added grants:
The Role of 27-hydroxycholesterol in Breast Cancer: A Population-Based Multiethnic Study
Development of a microfluidic primary cell editing platform (pCEP) for personal gene therapy
Northwestern University Lead Academic Participating Site
UM LAPs - UG1 Grant
UG1 - NCTN (Network Lead)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44AI028124-03
Application #
2064264
Study Section
Physiological Sciences Study Section (PSF)
Project Start
1989-06-01
Project End
1992-08-31
Budget Start
1991-09-01
Budget End
1992-08-31
Support Year
3
Fiscal Year
1991
Total Cost
Indirect Cost
Institution
Name
Baker Norton Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Miami
State
FL
Country
United States
Zip Code
33178
Related projects
NIH 1991
R44 AI
Nucleotide Dimers as Anti-HIV Agents
Hahn, Elliot F. / Baker Norton Pharmaceuticals, Inc.
NIH 1990
R44 AI
Nucleotide Dimers as Anti-HIV Agents
Hahn, Elliot F. / Baker Norton Pharmaceuticals, Inc.
Comments
Be the first to comment on Elliot Hahn's grant